EXPRESSION OF THE GP49 FAMILY ON MAST CELLS AND MONONUCLEAR PHAGOCYTES
EXPRESSION OF THE GP49 FAMILY ON MAST CELLS AND MONONUCLEAR PHAGOCYTES
批准号:
6099540
负责人:
HOWARD R KATZ
金额:
$16.87万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 1999-08-31
关键词:
DNA animal genetic material tag biological signal transduction cell adhesion cell cell interaction cell sorting cellular immunity enzyme linked immunosorbent assay gene expression genetic transcription glycoproteins human genetic material tag immunocytochemistry immunogenetics immunoglobulins laboratory mouse ligands mast cell molecular cloning phagocytes recombinant proteins secretion spleen
中文摘要
gp 49蛋白家族是免疫球蛋白(IG)的成员。
在小鼠中由肥大细胞优先表达的超家族
和单核吞噬细胞。两个高度同源的基因gp 49 A和gp 49 B,
编码gp 49家族的至少三个转录成员。的
gp 49 A基因编码gp 49 A1转录物,而gp 49 B基因编码
gp 49 B1和gp 49 B2交替转录物。gp 49 B1蛋白表达于
肥大细胞的表面,而gp 49 B2蛋白可能被分泌。后
用佛波醇肉豆蔻酸酯乙酸酯或IgE激活肥大细胞,
丝氨酸磷酸化,与蛋白激酶的存在一致
C磷酸化位点在胞质结构域的一个丝氨酸上。这
gp 49 B1的结构域,而不是gp 49 A1的结构域,也含有潜在的
磷酸化酪氨酸,是共有序列的重要部分
IG的某些受体进行信号转导所必需的
超家族gp 49家族的一个潜在的人类成员已经被确定。
同源cDNA克隆。gp 49 A1或gp 49 B1蛋白的过表达
在表达低天然水平gp 49的肥大细胞中的转染
蛋白质导致它们的聚集显著增加,
辅助性T细胞(Th)。因此,gp 49蛋白质家族可能
代表由肥大细胞表达的一类新的粘附分子,
单核吞噬细胞,可能有助于其与Th的相互作用,
也许是其他细胞。拟议研究的总体目标是
了解更多关于gp 49蛋白质家族成员如何介导
细胞聚集/粘附,以便了解它们的
可能参与细胞间的相互作用,
肥大细胞/单核吞噬细胞和表达
反配体。因此,提出研究的具体目标
1)确定gp 49 A1和gp 49 B1蛋白参与
细胞-细胞粘附,并鉴定表达反配体的细胞,
gp 49蛋白质家族; 2)定义
重组可溶性gp 49 B2蛋白与表达抗衡配体的细胞,
并评估gp 49 B2蛋白从哺乳动物细胞的分泌; 3)
为成员定义特定转录物和蛋白质的表达
在肥大细胞和单核吞噬细胞中,
4)确定小鼠gp 49与小鼠gp 49之间的关系。
家族和gp 49 B1-样人cDNA的表达,
反配体表达和可能的功能。预计各国
拟议研究的成功完成将加速
认识和理解的功能范围介导的
IG超家族的gp 49亚家族。因为肥大细胞和T细胞
在支气管哮喘的发病机制中起作用,
建立,拟议的研究涉及的总主题,
通过建立新的互动机制,
可能对炎症的协同作用,包括
航空公司.
英文摘要
The gp49 family of proteins are members of the immunoglobulin (Ig)
superfamily that in the mouse are preferentially expressed by mast cells
and mononuclear phagocytes. Two highly homologous genes, gp49A and gp49B,
encode at least three transcriptional members of the gp49 family. The
gp49A gene encodes gp49A1 transcripts, whereas the gp49B gene encodes
gp49B1 and gp49B2 alternate transcripts. gp49B1 protein is expressed on
the surface of mast cells, while gp49B2 protein may be secreted. Upon
mast cell activation with phorbol myristate acetate or IgE, gp49B1 is
serine phosphorylated, consistent with the presence of a protein kinase
C phosphorylation site on one serine of the cytoplasmic domain. This
domain of gp49B1, but not that of gp49A1, also contains a potentially
phosphorylated tyrosine that is an essential part of a consensus sequence
required for signal transduction by certain receptors of the Ig
superfamily. A potential human member of the gp49 family has been defined
by homology cDNA cloning. Over-expression of gp49A1 or gp49B1 protein by
transfection in mast cells that express low native levels of gp49
proteins results in a substantial increase in their aggregation with
activated T helper (Th) cells. Thus, the gp49 family of proteins likely
represents a new class of adhesion molecules expressed by mast cells and
mononuclear phagocytes that may facilitate their interaction with Th and
perhaps other cells. The broad objective of the proposed research is to
understand more about how members of the gp49 family of proteins mediate
cell aggregation/adhesion, so as to gain an appreciation of their
potential involvement in cell-cell interactions between several
populations of mast cells/mononuclear phagocytes and cells that express
a counterligand(s). Therefore, the specific aims of the proposed research
are: l) to define the participation of gp49A1 and gp49B1 proteins in
cell-cell adhesion, and to identify cells that express a counterligand(s)
for the gp49 family of proteins; 2) to define the interactions of
recombinant soluble gp49B2 protein with counterligand-expressing cells,
and to assess the secretion of gp49B2 protein from mammalian cells; 3)
to define the expression of specific transcripts and protein for members
of the entire mouse gp49 family in mast cell and mononuclear phagocyte
populations; and 4) to define the relationship between the mouse gp49
family and a gp49B1-like human cDNA in terms of cell expression,
counterligand expression, and possible function. it is anticipated that
the successful completion of the proposed studies will accelerate
recognition and understanding of the range of functions mediated by the
gp49 subfamily of the Ig superfamily. Because both mast cells and T cells
have roles in the pathogenesis of bronchial asthma that are firmly
established, the proposed studies relate to the overall theme of this
program by establishing a new mechanism for their interaction and their
possible synergistic contribution to inflammation, including that of the
airways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mouse Mast Cell Inhibitory Receptors of the gp49 Family
-
批准号:7422405
-
项目类别:
-
资助金额:$45.56万
-
财政年份:2007
-
负责人:HOWARD R KATZ
-
依托单位:
Mouse Mast Cell Inhibitory Receptors of the gp49 Family
-
批准号:7312453
-
项目类别:
-
资助金额:$45.65万
-
财政年份:2006
-
负责人:HOWARD R KATZ
-
依托单位:
Mouse Mast Cell Inhibitory Receptors of the gp49 Family
-
批准号:7098413
-
项目类别:
-
资助金额:$43.99万
-
财政年份:2005
-
负责人:HOWARD R KATZ
-
依托单位:
Group V Phospholipase A2 and Pulmonary Inflammation
-
批准号:8255636
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2003
-
负责人:HOWARD R KATZ
-
依托单位:
Group V Phospholipase A2 and Pulmonary Inflammation
-
批准号:8069976
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2003
-
负责人:HOWARD R KATZ
-
依托单位:
Group V Phospholipase A2 and Pulmonary Inflammation
-
批准号:7808767
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2003
-
负责人:HOWARD R KATZ
-
依托单位:
Group V Phospholipase A2 and Pulmonary Inflammation
-
批准号:7531872
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2003
-
负责人:HOWARD R KATZ
-
依托单位:
Group V Phospholipase A2 and Pulmonary Inflammation
-
批准号:7689183
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2003
-
负责人:HOWARD R KATZ
-
依托单位:
MAST CELL INHIBITORY RECEPTORS OF THE GP49 FAMILY
-
批准号:6654608
-
项目类别:
-
资助金额:$3.04万
-
财政年份:2002
-
负责人:HOWARD R KATZ
-
依托单位:
MAST CELL INHIBITORY RECEPTORS OF THE GP49 FAMILY
-
批准号:6496746
-
项目类别:
-
资助金额:$3.04万
-
财政年份:2001
-
负责人:HOWARD R KATZ
-
依托单位:
MAST CELL INHIBITORY RECEPTORS OF THE GP49 FAMILY
-
批准号:6353055
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2000
-
负责人:HOWARD R KATZ
-
依托单位:
MAST CELL INHIBITORY RECEPTORS OF THE GP49 FAMILY
-
批准号:6202252
-
项目类别:
-
资助金额:$32.71万
-
财政年份:1999
-
负责人:HOWARD R KATZ
-
依托单位:
REGULATION OF MAST CELL CYTOKINE PRODUCTION AND INHIBITION
-
批准号:6109812
-
项目类别:
-
资助金额:$28.57万
-
财政年份:1998
-
负责人:HOWARD R KATZ
-
依托单位:
GP49 FAMILY MEDIATED INTERACTIONS IN THE IMMUNE SYSTEM
-
批准号:6341674
-
项目类别:
-
资助金额:$23.44万
-
财政年份:1998
-
负责人:HOWARD R KATZ
-
依托单位:
Control of inflammatory diseases by gp49 receptors
-
批准号:6610138
-
项目类别:
-
资助金额:$33.14万
-
财政年份:1998
-
负责人:HOWARD R KATZ
-
依托单位:
Control of inflammatory diseases by gp49 receptors
-
批准号:6849230
-
项目类别:
-
资助金额:$33.14万
-
财政年份:1998
-
负责人:HOWARD R KATZ
-
依托单位:
GP49 FAMILY MEDIATED INTERACTIONS IN THE IMMUNE SYSTEM
-
批准号:6137221
-
项目类别:
-
资助金额:$22.76万
-
财政年份:1998
-
负责人:HOWARD R KATZ
-
依托单位:
Control of inflammatory diseases by gp49 receptors
-
批准号:7190478
-
项目类别:
-
资助金额:$31.42万
-
财政年份:1998
-
负责人:HOWARD R KATZ
-
依托单位:
GP49 FAMILY MEDIATED INTERACTIONS IN THE IMMUNE SYSTEM
-
批准号:2856068
-
项目类别:
-
资助金额:$22.09万
-
财政年份:1998
-
负责人:HOWARD R KATZ
-
依托单位:
GP49 FAMILY MEDIATED INTERACTIONS IN THE IMMUNE SYSTEM
-
批准号:2462158
-
项目类别:
-
资助金额:$15.67万
-
财政年份:1998
-
负责人:HOWARD R KATZ
-
依托单位: